These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16892508)

  • 1. [Glaucoma: early diagnosis is central].
    Praxis (Bern 1994); 2006 Jul; 95(27-28):2 p following 1094. PubMed ID: 16892508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 3. Glaucoma. Eye series. 7.
    Hodge C; Roberts T
    Aust Fam Physician; 2003 Aug; 32(8):643-4. PubMed ID: 12973875
    [No Abstract]   [Full Text] [Related]  

  • 4. [Juvenile glaucoma: a 17-year-old patient with liver transplantation].
    Mielke J; Schlote T
    Ophthalmologe; 2001 Mar; 98(3):308-9. PubMed ID: 11320822
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increasing ocular opacity in trisomy 13].
    Palmowski-Wolfe AM; Messerli J; Miny P; Weber P
    Ophthalmologe; 2005 Oct; 102(10):996-7, 998. PubMed ID: 16078062
    [No Abstract]   [Full Text] [Related]  

  • 6. The state of being noninferior.
    Musch DC; Gillespie BW
    Ophthalmology; 2006 Jan; 113(1):1-2. PubMed ID: 16389103
    [No Abstract]   [Full Text] [Related]  

  • 7. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit; latanoprost and herpes simplex keratitis.
    Camras CB
    Am J Ophthalmol; 2000 Feb; 129(2):271-2; author reply 272-3. PubMed ID: 10682992
    [No Abstract]   [Full Text] [Related]  

  • 8. From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.
    Stjernschantz JW
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1134-45. PubMed ID: 11328719
    [No Abstract]   [Full Text] [Related]  

  • 9. 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.
    Konstas AG; Mikropoulos DG; Embeslidis TA; Dimopoulos AT; Papanastasiou A; Haidich AB; Stewart WC
    Eye (Lond); 2010 Oct; 24(10):1606-13. PubMed ID: 20651749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.
    Nordmann JP; Berdeaux G
    Clin Ther; 2007 Aug; 29(8):1751-60; discussion 1750. PubMed ID: 17919556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F
    Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effectiveness of latanoprost for the treatment of pediatric glaucoma].
    Urban B; Bakunowicz-Lazarczyk A; Mrugacz M; Oziebło-Kupczyk M
    Klin Oczna; 2004; 106(1-2 Suppl):243-4. PubMed ID: 15510514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin esters--new directions in the treatment of glaucoma].
    Gafencu O; Cârstocea B; Ioniţă M
    Oftalmologia; 1999; 49(4):59-62. PubMed ID: 11021287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
    Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
    Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New agents for the treatment of glaucoma.
    Hill R
    West J Med; 1997 Feb; 166(2):140. PubMed ID: 9109333
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
    Soto J
    Pharmacoeconomics; 2006; 24(5):519-20; author reply 520-2. PubMed ID: 16706575
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of intraocular pressure in glaucoma subjects treated with Xalatan versus generic latanoprost.
    Egan P; Harris A; Siesky B; Abrams-Tobe L; Gerber AL; Park J; Holland S; Kim NJ; Januleviciene I
    Acta Ophthalmol; 2014 Aug; 92(5):e415-6. PubMed ID: 24373426
    [No Abstract]   [Full Text] [Related]  

  • 18. Latanoprost versus bimatoprost.
    Eisenberg D
    Ophthalmology; 2003 Sep; 110(9):1861-2; author reply 1862. PubMed ID: 13129903
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Kymes S
    Am J Ophthalmol; 2006 Aug; 142(2):354; author reply 354-5. PubMed ID: 16876536
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.